Account
Starcom co Performics.Convonix wins PharmEasy paid media mandate
MUMBAI: Performics.Convonix, part of Starcom India, in a significant development, has won the digital duties of pharma aggregator PharmEasy as part of a multi-agency pitch. The mandate involves all of paid media.
PharmEasy is a digital facilitator and helps patients connect with local pharmacy stores and diagnostic centres. It serves over 5 lakh families in India and is operational in seven cities, namely Mumbai, Delhi, Bengaluru, Kolkata, Pune, Jaipur and Ahmedabad. It has over 150 partner vendors.
Dharmil Sheth, Co-Founder of PharmEasy, said, “We provide consumers with quality health products and services at a click of a button and give them the highest possible savings in the shortest possible time. Performics.Convonix, like us is agile, ambitious, spirited and has a body of good solid work and rich insights on the pharma category. They are a great strategic partner to bring on board and their experience and expertise will give us maximum consumer connect across platforms and bang for the buck. While we reviewed several agencies, Performics.Convonix scored because of their strategic vision and thought-leadership on the category and the brand. It’s wonderful to have them on board to further fuel our expansion plans.”
Sarfaraz Khimani, Co-CEO Performics.Convonix, said, “This is a great win for us. PharmEasy is a brand that empowers consumers, and makes the best and most reliable health products and diagnostic services accessible to all. This is a brand built on trust, confidence, quality of service and excellence in product and we are pleased to partner with them in building the category. Healthcare is the largest utility vehicle and the digital healthcare industry in India is all set to boom, with a growing number of consumers opting to buy medicines the e-way. We look forward to making a significant difference to the PharmEasy brand. This will be a long and fruitful association.”
In the last financial year, PharmEasy has grown more than 200 %, with a growth rate of 15% month on month. PharmEasy has recently raised a Series B funding of $16 million in a round led by Bessemer Venture Partners and Orios Venture Partners.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
